Fenestrated endovascular aneurysm repair yielded a median survival of 6.9 years and 10-year aneurysm-related mortality of 6.7%, with an 8-year cumulative re-intervention rate of 27.7%.
What are the long-term outcomes and durability of fenestrated endovascular aneurysm repair (FEVAR) in patients with aneurysmal pathology?
FEVAR demonstrates acceptable long-term survival and low aneurysm-related mortality, though it carries a significant risk of re-intervention primarily due to graft-related complications, necessitating long-term surveillance.
Absolute Event Rate: 0% vs 0%
Abstract Introduction GLOBALSTAR is a registry of 1587 FEVAR cases from 15 UK centres (2003–2022), established by BSET. Aims were to report long-term outcomes for FEVAR. Methods Study design: retrospective cohort study of GLOBALSTAR. Inclusion criteria: aneurysmal pathology and custom-made FEVAR alone. Data were collected according to a standardised protocol. Time-to-event analyses were conducted for all-cause survival, aneurysm-related mortality and re-intervention. Log-rank sub-analyses were conducted for octogenarians and sexes. Results 1587 patients across 15 centres were included. Median age = 75 years 69–79,IQR and male = 87.9%. Patients were co-morbid with 45.0% IHD and 73.3% hypertension. All-cause survival at 3, 5 and 10 years was 79.5% 95% c.i., 77.6–81.6%, 64.2% 61.8–66.7% and 30.3% 27.4–33.4% with median survival = 6.9 years 6.6–7.2. Aneurysm-related mortality cumulative incidence = 6.7% at 10 years 5.4–8.1%. Secondary sac rupture was rare with 4.0 events/1000 patient-years. Cumulative incidence of re-intervention at 3, 5 and 8 years was 20.2% 18.2–22.3%, 24.4% 22.2–26.7% and 27.7% 25.3–30.2%. Graft-related complications accounted for 73.8% of re-interventions. Women had significantly worse 2-year survival (80.4%, 75.0- 86.3%) than men (86.4%, 84.6–88.3%) (P 0.05), driven by peri-operative mortality. Beyond 2 years, differences in survival were not significant. Octogenarians had equivalent survival (89.6% 86.5–92.7%) to non-octogenarians (92.2% 90.7–93.7%) up to 1 year (P = 0.098). Beyond 1 year, survival differences were significant. Octogenarians' median survival = 5.4 years 5.0–6.1. Conclusions Long-term outcomes for FEVAR appear acceptable, with low rates of secondary sac rupture. FEVAR carries risk, especially of re-intervention- driven by graft-related complications, highlighting the importance of surveillance. Peri-operative mortality was significantly higher in women, warranting further investigation.
Aurélien Guéroult (Sun,) reported a other. Fenestrated endovascular aneurysm repair yielded a median survival of 6.9 years and 10-year aneurysm-related mortality of 6.7%, with an 8-year cumulative re-intervention rate of 27.7%.